RegenVOX:Clinical trial of voicebox implants using tissue engineering

• Research type

  Research Study

• Full title

  RegenVOX: Phase I/IIa clinical trial of stem cell based tissue engineered partial laryngeal implants in adult patients with end-stage laryngotracheal stenosis with 24 months follow-up

• IRAS ID

  143447

• Contact name

  Martin Birchall

• Contact email

  m.birchall@ucl.ac.uk

• Sponsor organisation

  University College London (UCL) hereby represented by the UCL CCTU

• Eudract number

  2013-004359-18

• Clinicaltrials.gov Identifier

  NCT01977911

• REC name

  London - West London & GTAC Research Ethics Committee

• REC reference

  14/LO/0722

• Date of REC Opinion

  3 Jul 2014

• REC opinion

  Further Information Favourable Opinion